This document discusses long-acting reversible contraception (LARC) as the recommended first-line contraceptive option for adolescents. It describes the various LARC methods including intrauterine devices (IUDs) and implants, and their effectiveness rates of over 99%. Common misconceptions about LARC risks are dispelled, noting that LARC does not increase risks of infertility or pelvic inflammatory disease. Barriers to LARC use among teens are identified as lack of provider training and misinformation. Resources for provider training and patient referral are provided.